ai segmentation

Advancements in Breast Cancer Treatment: Highlights from the ESTRO 2023 Conference
The annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) took place in Vienna from 12 to 15 May, gathering over 6000 professionals.…
Radiotherapy for Esophageal Cancer – The Challenge of a Difficult Site
More than half a million people are diagnosed each year with esophageal cancer. It is the 8th most common cancer type and places sixth regarding…
Press Release: MVision AI raises 5.4M€ to make same-day cancer treatment the new standard
HELSINKI, Finland – March 23, 2023 MVision AI raises 5.4M€ to make same-day cancer treatment the new standard MVision AI is the first cloud-based AI-powered…
Perspectives on the implementation of AI-based solutions for Radiation Oncology – Where are we?
One of the main characteristics of humans, compared to most other living creatures, is the ability of making tools. Progress has been linked to discoveries…
MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform
Helsinki – 19th of January, 2022 – MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education…
AQUILAB Ushers In MVision’s Innovative and Guideline-Compliant AI Segmentation Solution to France
Helsinki – 29th of September 2021 – MVision AI, the leading service provider of guideline compliant radiotherapy software, announces a new distribution partnership with AQUILAB,…